key: cord-0814323-ouh2435m
authors: Suri, Aditi; Sindwani, Gaurav
title: Ketamine use in the COVID-19 era: be cautious!
date: 2020-07-29
journal: Korean J Anesthesiol
DOI: 10.4097/kja.20318
sha: fe03dd39dbf189a5fd2b2cb7c1bf2a5752ac2d93
doc_id: 814323
cord_uid: ouh2435m

nan

ditional measures against this highly infectious disease. At our center, we have seen a significant increase in bronchial secretions and the need for airway suctioning after the use of ketamine in these patients. Therefore, we suggest a cautious use of ketamine for sedation and anesthesia in this COVID era. To conclude, the use of ketamine for sedation and anesthesia should be cautious in suspected or confirmed COVID-19 patients, and the benefits of its use must be weighed against its associated increased risk of COVID-19 infection spread.

No potential conflict of interest relevant to this article was reported.

Recommendations for anesthesia in patients suspected of COVID-19 Coronavirus infection

Can glycopyrrolate come to the airway rescue in Covid-19 patients?

Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists

Ketamine versus ketamine pluses atropine for pediatric sedation: a meta-analysis

S(+)-ketamine : Current trends in emergency and intensive care medicine

Aditi Suri, https://orcid.org/0000-0002-6581-8968 Gaurav Sindwani, https://orcid.org/0000-0002-4646-5853